Chlorocebus sabaeus (green monkey): 103224834
Help
Entry
103224834 CDS
T04361
Symbol
CDKN2C
Name
(RefSeq) cyclin dependent kinase inhibitor 2C
KO
K06622
cyclin-dependent kinase inhibitor 2C
Organism
csab
Chlorocebus sabaeus (green monkey)
Pathway
csab01522
Endocrine resistance
csab04110
Cell cycle
csab04934
Cushing syndrome
csab05166
Human T-cell leukemia virus 1 infection
csab05202
Transcriptional misregulation in cancer
Brite
KEGG Orthology (KO) [BR:
csab00001
]
09140 Cellular Processes
09143 Cell growth and death
04110 Cell cycle
103224834 (CDKN2C)
09160 Human Diseases
09161 Cancer: overview
05202 Transcriptional misregulation in cancer
103224834 (CDKN2C)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
103224834 (CDKN2C)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
103224834 (CDKN2C)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
103224834 (CDKN2C)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Ank_2
Ank_4
Ank
Ank_5
Ank_3
Ank_KRIT1
DUF1843
ANK_LRRK2
Motif
Other DBs
NCBI-GeneID:
103224834
NCBI-ProteinID:
XP_007976975
Ensembl:
ENSCSAG00000001261
UniProt:
A0A0D9S7B4
LinkDB
All DBs
Position
20:complement(81964164..81970891)
Genome browser
AA seq
168 aa
AA seq
DB search
MAEPWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKLGNPEIARRLLLRG
ANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVE
FLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGAGGATNLQ
NT seq
507 nt
NT seq
+upstream
nt +downstream
nt
atggccgagccttgggggaacgagttggcgtccgcagctgccaggggggacctagagcaa
cttactagtttgttgcaaaataatgtaaacgtcaatgcacaaaatggatttggaaggact
gcgctgcaggttatgaaacttggaaatcccgagattgccaggagactactacttagaggt
gctaatcccgatttgaaagaccgaactggtttcgctgtcattcatgatgcggccagagca
ggtttcctggacactttacagactttgctggagtttcaagctgatgttaacatcgaggat
aatgaagggaacctgcccttgcacttggctgccaaagaaggccacctccgggtggtggag
ttcctggtgaagcacacggccagcaatgtggggcatcggaaccataagggggacaccgcc
tgtgatttggccaggctctatgggaggaacgaggttgttagcctgatgcaggcaaatggg
gctgggggagccacaaatcttcaataa
DBGET
integrated database retrieval system
